Vascular Cardio-Oncology: Vascular Endothelial Growth Factor inhibitors and hypertension

Volume: 115, Issue: 5, Pages: 904 - 914
Published: Feb 6, 2019
Abstract
Since the formation of new blood vessels is essential for tumour growth and metastatic spread, inhibition of angiogenesis by targeting the vascular endothelial growth factor (VEGF) pathway is an effective strategy for various types of cancer, most importantly renal cell carcinoma, thyroid cancer, and hepatocellular carcinoma. However, VEGF inhibitors have serious side effects, most importantly hypertension and nephropathy. In case of fulminant...
Paper Details
Title
Vascular Cardio-Oncology: Vascular Endothelial Growth Factor inhibitors and hypertension
Published Date
Feb 6, 2019
Volume
115
Issue
5
Pages
904 - 914
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.